Search By

Format
Articles (321)Events (35)News (2077)Interviews (77)
Publication Date

77 Results

Search By

ArticlesEventsNewsInterviews

From ‘Why Reject?’ to ‘How Release?’: Deepak Kasbi on the Cultural Shift in Pharma Quality

One question flipped pharma quality culture. Kasbi on why India still struggles with sustained compliance and what QA policing gets wrong.

Mr. Deepak Kasbi | May 02, 2026

Five Pillars Of Leadership That Built A Pharma Veteran: Shyam Khante’s 45-Year Pharma Journey

A gold medalist who swept floors, rejected an IIT-equivalent seat, and reached Technical Director at GSK by 34 — Mr. Shyam Khante's five leadership pillars are lived, not borrowed.

Mr. Shyam Khante | Apr 15, 2026

“Quality is Driven by Science” – Leadership Lessons from Zydus President Vikram Shukla

A President who moved from quality into operations because quality alone wasn't enough — Mr. Vikram Shukla makes the case that science, not inspections or ROI logic, is the only path to injectable credibility.

Mr. Vikram Shukla | Apr 10, 2026

Mr. Patrick Nieuwenhuizen on Contamination Control, AI, and Leadership

Patrick Nieuwenhuizen argues that in contamination control, technology is only as strong as the human behind it — and that AI, isolators, and robotics cannot replace scientific judgment.

Mr. Patrick Nieuwenhuizen | Apr 01, 2026

Mr. Fabio on GMP Compliance, Quality Systems & Inspection Readiness in Pharma

As GMP requirements tighten and systems go digital, most companies still struggle with recurring errors, weak communication, and inspection readiness gaps.

Mr. Fabio Geremia | Mar 31, 2026

Mr. Laxmikant Tiwari On Compliance, Quality, And Shop-Floor Ops

A 26-year operations veteran argues that compliance culture isn't built in boardrooms — it's built on shop floors, through listening, root-cause discipline, and a right-first-time mindset that most leaders still underestimate.

Mr. Laxmikant Tiwari | Mar 26, 2026

Natalia Vtyurina on Quality 5.0, Advanced Therapies and LEF Leadership

Natalia Vtyurina challenges the idea that quality is just compliance — arguing it must become a strategic driver of innovation, resilience, and patient safety in an era where advanced therapies demand far more than traditional systems can offer.

Natalia Vtyurina | Mar 26, 2026